Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or ...
Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...
23h
News-Medical.Net on MSNUnderstanding the phases and treatment options for Peyronie’s diseaseThe review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...
MALVERN, Pa., March 24, 2025 /CNW/ -- Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX ® (collagenase clostridium histolyticum, or CCH) for the treatment of ...
Peyronie's disease (PD) causes penile curvature. Its etiology is multifactorial, involving microtrauma and genetic factors.
Endo, Inc. (OTCQX: NDOI) announced today the launch of a first-of-its-kind initiative for a pharmaceutical company: the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results